Transcat (TRNS)
Provides calibration and compliance services alongside test-and-measurement instrument sales and rentals.
$90.61
vs last close−1.22 (−1.32%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Dec 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 65 | 65 | 71 | 67 | 68 | 68 | 77 | 77 | 82 | 84 | 89 | 93 |
| Cost of revenue | 44 | 44 | 47 | 44 | 47 | 47 | 51 | 51 | 56 | 59 | 59 | 62 |
| Gross profit | 21 | 21 | 24 | 23 | 21 | 21 | 26 | 26 | 27 | 25 | 30 | 31 |
| 17 | 17 | 15 | 18 | 17 | 17 | 19 | 19 | 23 | 25 | 27 | 27 | |
| 17 | 17 | 15 | 18 | 17 | 17 | 19 | 19 | 23 | 25 | 28 | 27 | |
| Selling & marketing | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 11 | 11 | 11 | 11 |
| General & administrative | 9 | 9 | 7 | 10 | 9 | 9 | 10 | 10 | 13 | 14 | 16 | 16 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 4 | 4 | 9 | 5 | 4 | 4 | 7 | 7 | 4 | 0 | 3 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −1 | −2 | 0 | −2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 2 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 |
| Income before tax | 4 | 4 | 10 | 5 | 4 | 4 | 6 | 6 | 2 | −1 | 3 | 2 |
| Income tax expense | 1 | 1 | 3 | 1 | 0 | 0 | 2 | 2 | 1 | 0 | 1 | 1 |
| Net income from continuing operations | 3 | 3 | 7 | 4 | 3 | 3 | 4 | 4 | 1 | −1 | 2 | 1 |
| Net income | 3 | 3 | 7 | 4 | 3 | 3 | 4 | 4 | 1 | −1 | 2 | 1 |
| EPS, basic | $0.39 | $0.39 | $0.82 | $0.49 | $0.36 | $0.36 | $0.49 | $0.48 | $0.14 | −$0.12 | $0.21 | $0.14 |
| EPS, diluted | $0.38 | $0.38 | $0.81 | $0.48 | $0.35 | $0.35 | $0.48 | $0.48 | $0.14 | −$0.12 | $0.21 | $0.14 |
| Weighted average shares, basic | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Weighted average shares, diluted | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| EBITDA | 8 | 8 | 13 | 9 | 8 | 8 | 12 | 12 | 10 | 7 | 11 | 11 |
| Depreciation & amortization | 4 | 4 | 4 | 4 | 4 | 4 | 6 | 6 | 6 | 7 | 7 | 7 |
| EBIT | 4 | 4 | 10 | 5 | 4 | 4 | 7 | 7 | 3 | 0 | 4 | 4 |